Meropenem For Ceftazidime-Avibactam—Resistant K. pneumoniae

Article

Researchers from the University of Pittsburgh find a way to successfully treat a patient with ceftazidime-avibactam-resistant Klebsiella pneumoniae.

Clinicians used meropenem to successfully treat a patient with bacteremia due to Klebsiella pneumoniae that carried a mutation in the blaKPC-3 gene, and was resistant to ceftazidime-avibactam.

Recent Videos
© 2024 MJH Life Sciences

All rights reserved.